Woodcock Throws Weight Behind Push For New Legislative ‘Substantial Evidence’ Standard For Rare Disease Drugs
Woodcock said the proposal would not compromise the agency's "gold standard" for drug approvals, but others are less convinced. (Shutterstock) 
